CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION

Show other versions (1)

Aim. To evaluate the clinical results of thrombolytic therapy with thrombolytics (alteplase, tenecteplase) in patients with ST segment elevation myocardial infarction (STEMI). Material and methods. Patients with STEMI (n=181) included in the study were split into two groups depending on the thrombol...

Full description

Bibliographic Details
Main Authors:	L. A. Bondarenko, L. E. Rudakova, F. K. Rakhmatullov, T. P. Kostrikova, I. I. Kapustina
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	st segment elevation myocardial infarction thrombolysis alteplase tenecteplase
Online Access:	https://www.rpcardio.online/jour/article/view/583

Similar Items

THE RELEVANCE OF THROMBOLYTIC THERAPY IN ST ELEVATION MYOCARDIAL INFARCTION
by: N. V. Teplova, et al.
Published: (2014-05-01)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
by: Nishita Singh, et al.
Published: (2023-01-01)

Feasibility of switching from alteplase to tenecteplase for stroke thrombolysis – A retrospective cohort analysis
by: Vilhelm Sjögren, et al.
Published: (2023-06-01)

COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE
by: V. V. Omel'yanovskiy, et al.
Published: (2016-01-01)

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)

Tenecteplase and alteplase for thrombolysis of acute ischemic stroke within 4.5 hours: An efficacy and safety study
by: Nikita Dhar, et al.
Published: (2022-01-01)

Safety and efficacy of streptokinase, tenecteplase, and reteplase in patients diagnosed with ST-elevation myocardial infarction: A comparative study
by: Bhargavi Neela, et al.
Published: (2020-01-01)

Use of thrombolytic agents for ST-elevation myocardial infarction care in India: An expert consensus
by: Arun Chopra, et al.
Published: (2021-01-01)

RISKS AND BENEFITS OF REPERFUSION STRATEGIES IN ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION
by: T. M. Poponina, et al.
Published: (2010-10-01)

THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. V. Konstantinova, et al.
Published: (2016-01-01)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Ziyi Shen, et al.
Published: (2023-08-01)

Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials
by: Jian Huang, et al.
Published: (2024-12-01)

Evaluation of the tolerability and effectiveness of Tenecteplase in patients with ST-Segment-Elevation Myocardial Infarction in a Secondary Hospital in Malaysia: A Retrospective Case Series
by: Kin Wei Chua, MSc,Med(ClinEpi), et al.
Published: (2021-01-01)

Implementation of a Tenecteplase Protocol for Treatment of Acute Ischemic Stroke in a Health System
by: Alexis Pace, et al.
Published: (2024-04-01)

Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials
by: Hassan Kobeissi, et al.
Published: (2023-01-01)

COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE
by: E. S. Mazur, et al.
Published: (2017-09-01)

Effectiveness and Safety of Tecneplase vs. Alteplase in the Acute Treatment of Ischemic Stroke
by: Ángel Estella, et al.
Published: (2022-09-01)

In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
by: Yilin Yang, et al.
Published: (2023-02-01)

Selection of P2Y12 antagonist in patients with myocardial infarction who received thrombolytic therapy. Results of annual follow-up of TREAT study patients
by: O. V. Averkov, et al.
Published: (2019-09-01)

Ischemic stroke complicating thrombolytic therapy with tenecteplase for ST elevation myocardial infarction: two case reports
by: Salim Arous, et al.
Published: (2017-06-01)

Real-world data of tenecteplase vs. alteplase in the treatment of acute ischemic stroke: a single-center analysis
by: Yu Yao, et al.
Published: (2024-04-01)

In vitro examination of the thrombolytic efficacy of tenecteplase and therapeutic ultrasound compared to rt-PA
by: Tobias Frühwald, et al.
Published: (2019-08-01)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
by: Xu N, et al.
Published: (2018-07-01)

The efficacy and safety of tenecteplase compared with alteplase in adult patients with acute ischemic stroke: an updated systematic review and meta-analysis of ten randomized controlled trials
by: Karthikeyan Chinniah, et al.
Published: (2023-10-01)

A study on clinical profile and in-hospital outcome of elderly patients receiving thrombolytic therapy for ST elevation myocardial infarction
by: Darshan P Thakkar, et al.
Published: (2022-01-01)

Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in ST segment elevation acute myocardial infarction
by: Tomašević Miloje, et al.
Published: (2008-01-01)

Different doses of tenecteplase vs. alteplase for acute ischemic stroke within 4.5 hours of symptom onset: a network meta-analysis of randomized controlled trials
by: Huo Liang, et al.
Published: (2023-06-01)

Reasons for not receiving thrombolytic therapy in patients with acute myocardial infarction admitted to Bu-Ali Sina Hospital in Qazvin (2013-14)
by: MM. Daei, et al.
Published: (2017-04-01)

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
by: Mingfeng Zhai, et al.
Published: (2023-05-01)

Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change?
by: O. V. Averkov, et al.
Published: (2018-09-01)

APPROACHES TO INCREASE THE AVAILABILITY AND EFFECTIVENESS OF PRE-HOSPITAL THROMBOLYSIS IN REAL CLINICAL PRACTICE
by: L. A. Ostroumova, et al.
Published: (2015-12-01)

Impact of ST‐Segment–Elevation Myocardial Infarction Regionalization Programs on the Treatment and Outcomes of Patients Diagnosed With Non–ST‐Segment–Elevation Myocardial Infarction
by: Juan Carlos C. Montoy, et al.
Published: (2021-02-01)

Tenecteplase Thrombolysis in Posterior Circulation Stroke
by: Fana Alemseged, et al.
Published: (2021-08-01)

ST-Segment elevation acute myocardial infarction prehospital thrombolytic therapy: Chinese expert consensus
by: Hongbin Yan, et al.
Published: (2018-01-01)

Effectiveness of alteplase intravenous thrombolysis combined with butylphthalide in patients with acute severe cerebral infarction
by: Zhengqian Wang, et al.
Published: (2022-12-01)

Pharmaco‐Invasive Strategy: The Answer to Improving ST‐Elevation–Myocardial Infarction Care
by: Amgad Mentias, et al.
Published: (2020-06-01)

Response to thrombolytic agents in acute myocardial infarction in opium abusers versus non-abusers
by: Seyed Mohammad Hashemi Jazi, et al.
Published: (2012-01-01)

Thrombolysis for acute ischemic stroke by tenecteplase in the emergency department of a Moroccan hospital
by: Ahmed Belkouch, et al.
Published: (2015-05-01)

TENECTEPLASE AS A NEW MEDICATION IN MANAGING NO-REFLOW
by: Milan Živković, et al.
Published: (2012-03-01)

Multimarker Risk Stratification in Patients With Acute Myocardial Infarction
by: Michelle L. O'Donoghue, et al.
Published: (2016-05-01)